BioView Ltd. reported that it has signed a substantial cooperation agreement in China to market a product for early detection of lung cancer, using the company's automating systems. Under the terms of the agreement, Livzon Cynvenio Diagnostics Ltd. will order from BioView, systems worth at least ILS 70 million over five years. Livzon Cynvenio Diagnostics is a partnership of Chinese company Livzon Pharmaceuticals and Cynvenio.